Addiction Medicine — Medicare Part B billing by state
39 physician groups whose primary specialty is Addiction Medicine billed $4.1M to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Oklahoma | $1.3M | $1.2M | 1 | $1.2M | 76,815 | 6,030 | 76,815 |
| Minnesota | $521K | $509K | 1 | $509K | 6,904 | 2,572 | 6,904 |
| Ohio | $445K | $430K | 4 | $107K | 7,188 | 3,164 | 1,797 |
| Tennessee | $385K | $355K | 8 | $44K | 11,310 | 6,966 | 1,414 |
| Virginia | $294K | $282K | 6 | $47K | 5,577 | 1,890 | 930 |
| Rhode Island | $198K | $201K | 1 | $201K | 3,896 | 3,253 | 3,896 |
| Massachusetts | $177K | $187K | 2 | $93K | 2,712 | 1,405 | 1,356 |
| Indiana | $172K | $160K | 2 | $80K | 2,759 | 1,082 | 1,380 |
| Maryland | $126K | $130K | 3 | $43K | 1,530 | 599 | 510 |
| Vermont | $100K | $97K | 2 | $48K | 1,539 | 345 | 770 |
| Kentucky | $97K | $86K | 2 | $43K | 1,396 | 492 | 698 |
| Pennsylvania | $93K | $90K | 1 | $90K | 1,507 | 890 | 1,507 |
| Florida | $92K | $88K | 2 | $44K | 1,179 | 256 | 590 |
| California | $62K | $55K | 2 | $27K | 896 | 257 | 448 |
| Missouri | $41K | $35K | 2 | $17K | 714 | 257 | 357 |
| New Jersey | $41K | $41K | 1 | $41K | 647 | 172 | 647 |
| District of Columbia | $38K | $43K | 1 | $43K | 403 | 269 | 403 |
| Maine | $30K | $29K | 1 | $29K | 368 | 298 | 368 |
| New York | $27K | $28K | 2 | $14K | 506 | 455 | 253 |
| Michigan | $18K | $19K | 1 | $19K | 202 | 190 | 202 |
| New Mexico | $13K | $13K | 1 | $13K | 290 | 160 | 290 |
| Texas | $12K | $11K | 1 | $11K | 145 | 86 | 145 |
| Georgia | $12K | $12K | 1 | $12K | 106 | 105 | 106 |
| Washington | $11K | $12K | 1 | $12K | 172 | 62 | 172 |
| North Carolina | $3K | $3K | 1 | $3K | 55 | 25 | 55 |
| Arizona | $939 | $916 | 1 | $916 | 99 | 25 | 99 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
9 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| G0481 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $296K | 1,969 | OKMNOHTNVA |
| G0482 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $289K | 1,482 | OKMNOHTNVA |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | $5K | 44,250 | OKMNOHTNVA |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $2K | 18,690 | OKMNOHTNVA |
| J2250 · Injection, midazolam hydrochloride, per 1 mg top by services | $588 | 5,018 | OKMNOHTNVA |